• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Atricure(ATRC.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec11
AtriCure Inc. Completes First-Ever Clinical Treatment for Atrial Fibrillation Using Dual-Energy Platform
13:01
Oct30
Thibault and Needham Reiterate Buy Rating on Atricure
11:42
Oct29
Atricure released FY2025 Q3 earnings on October 29 After-Market EST, actual revenue USD 134.27 M (forecast USD 131.25 M), actual EPS USD -0.0055 (forecast USD -0.1145)
23:00
Atricure released FY2025 9 Months Earnings on October 29 After-Market EST, with actual revenue of USD 394.03 M and EPS of USD -0.282
23:00
AtriCure Reports Q3 2025 Beat, Raises Full-Year Revenue Guidance
20:12
Oct22
Atricure to Release FY2025 Q3 Earnings on October 29 After-Market (EST), Forecast Revenue USD 131.25 M, EPS USD -0.1145
00:18

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 134.27 M, Net Income -267 K, EPS -0.0055

Jul29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 136.14 M, Net Income -6.19 M, EPS -0.1297

Apr29
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 123.62 M, Net Income -6.747 M, EPS -0.1423

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More